Cogstate Ltd (AU:CGS) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Cogstate Ltd has announced a partnership with Medidata to deliver a unified solution for central nervous system disease assessments, marking a significant strategic expansion for the company. This collaboration is expected to boost Cogstate’s sales, with the first contract anticipated soon. Additionally, Cogstate’s recent financial performance shows promising growth, supported by a new share buyback initiative.
For further insights into AU:CGS stock, check out TipRanks’ Stock Analysis page.
